Department of Zoology, University of Guelph, Guelph, Ontario, Canada N1G 2W1Elsevier Inc.General & Comparative EndocrinologyB A L L A N T Y N E , J . S . , J O H N . T . M . A N D G E O R G E , J . C . 1988. The effects of glucagon on hepatic mitochondrial ...
PENICK S. B,HINKLE LAWRENCE E - 《American Journal of Clinical Nutrition》 被引量: 37发表: 0年 Effects of heat exposure on adrenergic modulation of insulin and glucagon secretion in sheep. The effects of heat exposure on the adrenergic modulation of pancreatic secretion were investigated. Five ...
Effects of glucagon, insulin, and the eel serum on protein, glycogen, and gluconeogenesis in the eel liver cells in primary culture were investigated. The cells cultured in the medium with 0.25μM glucagon for 6 days synthesized glucose and glycogen from 14C-pyruvate by 37 and 2.5 times higher...
3-Hydroxybutyrate, a key constituent of ketone bodies, has been found to favor improvements in cardiovascular disease. However, whether the protective effect of diabetes on aortic dissection is mediated by 3-hydroxybutyrate is unclear. We aimed to investigate the causal effects of diabetes on the ...
The glucagon-like peptide-1 receptor (GLP1R) agonist liraglutide improves glycemic control and reduces body weight of adult type 2 diabetic patients. However, efficacy and safety of liraglutide in adolescents has not been systematically investigated. Furthermore, possible pro-proliferative effects of GLP...
Interestingly, current research now focuses on dual agonist approaches that include GLP-1 receptor agonism to enable synergistic effects on weight loss or associated functions. GLP-1 is secreted from the same intestinal cells as the anorectic gut peptide, Peptide YY3–36 (PYY3–36), thus this ...
Acute effects of glucagon on the liverGöttingen, Univ., Diss., 1974.doi:10.1038/s41574-018-0011-7MorrisAlanNature Reviews Endocrinology
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimer’s disease. Alzheimer’s Dement. 18, e062415 (2022). Google Scholar Manavi, M. A. Neuroprotective effects of glucagon-like ...
Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus: Systematic review and meta-analysis of cardiovascular outcomes trials 2019, Circulation 11. Microv...
Then, recommendations could be further refined to include not only the total quantity of whole grains, but also more specifically for the types of grains consumed based on the potential health benefit. It is likely that the improvements seen from increasing whole grain consumption come from the ...